As a follow-up to my recent post on treatment options for advanced sarcoma, I wanted to highlight a few of the clinical trials we currently have open here at Roswell Park. We continue to explore new drugs and combinations of drugs that show promise in treating this diverse group of cancers.

Click below to learn about these studies and watch my video for a basic overview of what they entail.   

• A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma
• A Randomized Phase 3, Multicenter, Open Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma